An interventional study of Early vitrectomy in Myopia, Degenerative, sponsored by Seoul Retina Investigator Group. Status unknown at 10 sites in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2011-03-29.
Sponsored by Seoul Retina Investigator Group · Not applicable, Interventional, and Treatment
This study is designed to identify the effect of current vitreous surgery for symptomatic macular tractional maculopathy.
Characteristics of this study is as below
Degenerative myopia is relatively common disorder, especially in Korean, Japanese and Chinese.
Choroidal neovascularization is well-noted cause of VA deterioration, but nowadays, with improvement of diagnostic tools, such as OCT, VA deterioration from myopic tractional maculopathy is being concerned as well.
But till now, the necessity of early vitrectomy on MTM is controversial. By now some clinicians prefer conservative treatment, which means pars plana vitrectomy would be postponed till structural change such as macular hole formation is noticed. And the others prefer early vitrectomy, which means pars plana vitrectomy should be performed when the symptom begins.
In this study, investigators try to verify the validity of early vitrectomy comparing conservative treatment.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 40 is below the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Seoul Retina Investigator Group is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Eyes which do not undergo early vitrectomy at the time of enrollment. Surgical intervention would be performed when full-thickness macular hole or vision deterioration occurs
Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine green dye assisted internal limiting membrane peeling
Procedure: Early vitrectomy
Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine green dye assisted internal limiting membrane peeling
Also known as: pars plana vitrectomy for macular tractional maculopathy
Best Corrected Visual acuity
Time frame: 48 weeks
Rate of occurrence of full-thickness macular hole
Time frame: 48 weeks
This study is status unknown, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul Retina Investigator Group